DOI: 10.1055/s-00044025

Annals of the National Academy of Medical Sciences (India)

Referenz

Sriram K, Insel PA.
Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.

Clin Pharmacol Ther 2020;
108 (02) 236-241

Bibliographische Angaben herunterladen